Quick Answer
Scinai Immunotherapeutics Ltd. reported Total Assets of $13.45 million for fiscal year 2024.
Scinai Immunotherapeutics Ltd. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2024 | $13.45M | -23.0% |
| 2023 | $17.47M | -35.4% |
| 2022 | $27.07M | -15.5% |
| 2021 | $32.04M | -43.7% |
| 2020 | $56.91M | -50.8% |
| 2019 | $115.75M | +9.4% |
| 2018 | $105.84M | +29.6% |
| 2017 | $81.69M | +171.3% |
| 2016 | $30.11M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| March 31, 2023 | $23.29M | — | -13.9% |
| December 31, 2022 | $27.07M | — | — |
- Scinai Immunotherapeutics Ltd. showed a decrease of -23.0% in Total Assets compared to the prior fiscal year.
- Over the 2016–2024 period, Scinai Immunotherapeutics Ltd.’s total assets has declined by 55.3% (from $30.11 million to $13.45 million).
- The most recent figure is from Scinai Immunotherapeutics Ltd.’s fiscal year 2024 report (Form 20-F), filed with the SEC on May 7, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: